Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FBSDN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,330
Award facts
- Contract value 100% obligated
- $11,330.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,330.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 100 Unit Vials. The contract is a firm fixed-price delivery order with an ultimate completion date of December 30, 2025, and was issued without a set-aside designation. DMS Pharmaceutical Group competes directly in unrestricted federal procurement, demonstrating competitive capability across the broader pharmaceutical supply market. The company serves as a critical supplier within the Department of Defense's pharmaceutical distribution network, leveraging its small business status to provide specialized pharmaceutical products to military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $500 million ceiling value and completion date of December 31, 2036. The PPV-G GEN V contract positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors within the broader $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs across worldwide Department of Defense healthcare facilities. The company's extensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with demonstrated performance across numerous delivery orders spanning diverse therapeutic categories.
Quick answers
Who was awarded contract SPE2DR26FBSDN?
SPE2DR26FBSDN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FBSDN worth?
The government has obligated $11,330 on SPE2DR26FBSDN.
Is contract SPE2DR26FBSDN an order under another contract?
Yes. SPE2DR26FBSDN is a delivery order under SPE2DR25D9158, an indefinite delivery contract.
Was contract SPE2DR26FBSDN competed?
The extent of competition for SPE2DR26FBSDN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award